8 results match your criteria HIV Early Recognition and Rapid Testing

  • Page 1 of 1

Ocular Syphilis Presenting as Acute Necrotizing Retinitis in a Human Immunodeficiency Virus-Positive Patient.

J Glob Infect Dis 2020 Jul-Sep;12(3):149-151. Epub 2020 Aug 29.

Department of Ophthalmology, AIIMS, Bhubaneswar, Odisha, India.

The incidence of ocular syphilis is increasing in the developing world even in the era of effective human immunodeficiency virus (HIV) treatment, as there is a potential increase of high-risk sexual behavior. Ocular involvement in the form of uveitis is seen in all stages of syphilis. Diagnosis begins with ophthalmologic examination, but requires serologic testing for confirmation. Read More

View Article and Full-Text PDF

A Novel HIV-1 RNA Testing Intervention to Detect Acute and Prevalent HIV Infection in Young Adults and Reduce HIV Transmission in Kenya: Protocol for a Randomized Controlled Trial.

JMIR Res Protoc 2020 Aug 7;9(8):e16198. Epub 2020 Aug 7.

Kenya Medical Research Institute - Wellcome Trust Research Programme, Kilifi, Kenya.

Background: Detection and management of acute HIV infection (AHI) is a clinical and public health priority, and HIV infections diagnosed among young adults aged 18 to 39 years are usually recent. Young adults with recent HIV acquisition frequently seek care for symptoms and could potentially be diagnosed through the health care system. Early recognition of HIV infection provides considerable individual and public health benefits, including linkage to treatment as prevention, access to risk reduction counseling and treatment, and notification of partners in need of HIV testing. Read More

View Article and Full-Text PDF

Standalone operation of an EGOFET for ultra-sensitive detection of HIV.

Biosens Bioelectron 2020 May 19;156:112103. Epub 2020 Feb 19.

Instituto de Microelectrónica de Barcelona, IMB-CNM (CSIC), C/ del Til·lers, Campus UAB, 08193, Bellaterra, Barcelona, Spain; Catalan Institution for Research and Advanced Studies (ICREA), P.L. Companys 23, 08010, Barcelona, Spain. Electronic address:

A point-of-care (POC) device to enable de-centralized diagnostics can effectively reduce the time to treatment, especially in case of infectious diseases. However, many of the POC solutions presented so far do not comply with the ASSURED (affordable, sensitive, specific, user-friendly, rapid and robust, equipment free, and deliverable to users) guidelines that are needed to ensure their on-field deployment. Herein, we present the proof of concept of a self-powered platform that operates using the analysed fluid, mimicking a blood sample, for early stage detection of HIV-1 infection. Read More

View Article and Full-Text PDF

Cryptococcal immune reconstitution inflammatory syndrome.

Curr Opin Infect Dis 2013 Feb;26(1):26-34

Research Centre for Infection and Immunity, Division of Clinical Sciences, St. George's University of London, London, UK.

Purpose Of Review: The epidemiology and pathogenesis of, and risk factors for, cryptococcal immune reconstitution inflammatory syndrome (CM-IRIS) are reviewed with an emphasis on how new insights inform a rational management approach and prevention strategies.

Recent Findings: Risk factors for paradoxical CM-IRIS are a low inflammatory response and CD4 cell count at baseline, rapid immune restoration from this low baseline, and a high organism or antigen load at baseline and at antiretroviral therapy (ART) initiation. Detailed immune mechanisms are still unclear. Read More

View Article and Full-Text PDF
February 2013

Surveillance of transfusion-transmissible infections comparison of systems in five developed countries.

Transfus Med Rev 2012 Jan 25;26(1):38-57. Epub 2011 Sep 25.

National Epidemiology and Surveillance, Canadian Blood Services, 1800 Alta Vista Drive, Ottawa, Ontario, Canada K1G 4J5.

Most industrialized countries maintain surveillance programs for monitoring transmissible infection in blood donations, revising approaches to methodology and risk assessment as new threats emerge. A comparison of programs in the United States, Canada, France, the UK, and Australia indicates that they have similar function, although the structure of blood programs vary as does the extent and nature of formal ties with public health. The emergence of HIV in the late 1970s and early 1980s was key in recognizing that surveillance systems specific to blood transfusion were essential. Read More

View Article and Full-Text PDF
January 2012

Treatment and prevention of multidrug-resistant tuberculosis.

Drugs 1999 Oct;58(4):633-61

Institute of Tropical Medicine, Antwerp, Belgium.

Multidrug-resistant tuberculosis (MDRTB), which is defined as combined resistance to isoniazid and rifampicin, is a 'man-made' disease that is caused by improper treatment, inadequate drug supplies or poor patient supervision. Patients with MDRTB face chronic disability and death, and represent an infectious hazard for the community. Cure rates of 96% have been achieved but require prompt recognition of the disease, rapid accurate susceptibility results, and early administration of an individualised re-treatment regimen. Read More

View Article and Full-Text PDF
October 1999

An eleven year follow-up of delayed-type hypersensitivity testing for the identification of HIV-1 infected patients at increased risk of developing AIDS.

Scand J Infect Dis 1996 ;28(2):125-30

Department of Dermatovenereology (Venhälsan), Södersjukhuset, Stockholm, Sweden.

The objective of this study was to investigate whether testing of delayed-type hypersensitivity (DTH) to recall antigens could be used to identify HIV-1 infected patients at increased risk of death or developing AIDS. Eighty-five HIV-1 infected Swedish homosexual men were tested for DTH using a commercially available kit with 7 recall antigens (Multitest, Mérieux). The patients were followed prospectively for 11 years or until death. Read More

View Article and Full-Text PDF
December 1996

Laboratory diagnosis of HIV-1 and HIV-2 in Africa.

AIDS 1991 ;5 Suppl 1:S93-101

Laboratoire de Bacteriologie et Virologie, University of Dakar, Senegal.

View Article and Full-Text PDF
  • Page 1 of 1